These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 8617238
1. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. EMBO J; 1996 Apr 15; 15(8):1914-23. PubMed ID: 8617238 [Abstract] [Full Text] [Related]
2. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, Sluiter W. Biochem Biophys Res Commun; 1997 Jan 03; 230(1):44-8. PubMed ID: 9020057 [Abstract] [Full Text] [Related]
7. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. Craxton A, Shu G, Graves JD, Saklatvala J, Krebs EG, Clark EA. J Immunol; 1998 Oct 01; 161(7):3225-36. PubMed ID: 9759836 [Abstract] [Full Text] [Related]
8. Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle. Larsen JK, Yamboliev IA, Weber LA, Gerthoffer WT. Am J Physiol; 1997 Nov 01; 273(5):L930-40. PubMed ID: 9374719 [Abstract] [Full Text] [Related]
9. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Suzuki K, Hino M, Hato F, Tatsumi N, Kitagawa S. Blood; 1999 Jan 01; 93(1):341-9. PubMed ID: 9864179 [Abstract] [Full Text] [Related]
12. Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils. Niwa M, Hotta K, Kanamori Y, Hatakeyama D, Hirade K, Katayama M, Hara A, Mori H, Ito H, Kato K, Matsuno H, Uematsu T, Kozawa O. Eur J Pharmacol; 2003 Apr 18; 466(3):245-53. PubMed ID: 12694807 [Abstract] [Full Text] [Related]
16. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Birkenkamp KU, Tuyt LM, Lummen C, Wierenga AT, Kruijer W, Vellenga E. Br J Pharmacol; 2000 Sep 18; 131(1):99-107. PubMed ID: 10960075 [Abstract] [Full Text] [Related]
17. The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts. Chae HJ, Chae SW, Chin HY, Bang BG, Cho SB, Han KS, Kim SC, Tae KC, Lee KH, Kim DE, Im MK, Lee SJ, Chang JY, Lee YM, Kim HM, Kim HH, Lee ZH, Kim HR. Bone; 2001 Jan 18; 28(1):45-53. PubMed ID: 11165942 [Abstract] [Full Text] [Related]
18. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1. Matthews JS, O'Neill LA. Cytokine; 1999 Sep 18; 11(9):643-55. PubMed ID: 10479400 [Abstract] [Full Text] [Related]
19. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. Fukunaga R, Hunter T. EMBO J; 1997 Apr 15; 16(8):1921-33. PubMed ID: 9155018 [Abstract] [Full Text] [Related]
20. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Hashimoto S, Matsumoto K, Gon Y, Furuichi S, Maruoka S, Takeshita I, Hirota K, Yodoi J, Horie T. Biochem Biophys Res Commun; 1999 May 10; 258(2):443-7. PubMed ID: 10329406 [Abstract] [Full Text] [Related] Page: [Next] [New Search]